GnRHa protects the ovarian reserve by reducing endoplasmic reticulum stress during cyclophosphamide-based chemotherapy
Abstract Chemotherapy-induced ovarian dysfunction is a serious adverse effect in premenopausal patients with cancer. Gonadotrophin-releasing hormone analogs (GnRHa) protect ovarian function, but its molecular mechanisms have not yet been determined. In this study, we attempted to determine the previ...
Saved in:
Main Authors: | Xiaolin Li, Sixuan Liu, Xuan Chen, Run Huang, Lisi Ma, Huaiyu Weng, Yang Yu, Xiangyun Zong |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/5f42003b8ee944e89ba1d69d78f71cb5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An alternative pathway for membrane protein biogenesis at the endoplasmic reticulum
by: Sarah O’Keefe, et al.
Published: (2021) -
The use of GnRH analogs in preserving ovarian function during chemotherapy
by: Omar M. Odeh, et al.
Published: (2021) -
Endoplasmic Reticulum-Mitochondria Contacts: A Potential Therapy Target for Cardiovascular Remodeling-Associated Diseases
by: Yu Wang, et al.
Published: (2021) -
Clinicopathological significance of endoplasmic reticulum stress proteins in ovarian carcinoma
by: Soma Samanta, et al.
Published: (2020) -
The flexibility and dynamics of the tubules in the endoplasmic reticulum
by: Pantelis Georgiades, et al.
Published: (2017)